the centrosome that is normally involved in separating the chromosomes during mitosis is relocated and anchors just below the surface of the apical membrane. 5 During the conversion of a centriole to a basal body, distal and subdistal centriolar appendages transform into transition fibers and basal feet, which act as physical attachments to the plasma membrane (►Fig. 1). These elements are also required to establish the orientation of the basal body in the plasma membrane. 6 Distal to the transition fibers resides the ciliary transition zone, which functions as a gate and regulates the entry and exit of proteins into and out of the cilium.
7,8
Vesicles with membrane proteins are targeted here to be integrated into the ciliary membrane, a process that is coordinated by the BBSome, a complex of proteins that are mutated in Bardet-Biedl syndrome (BBS). 9, 10 Vesicle delivery to the cilium contributes to the establishment of a highly specialized ciliary membrane that contains various receptors and signaling proteins. 11 Within the cilium proteins are transported from base to tip and back over the axonemal microtubules (►Fig. 1). This transport, first described in unicellular algae, is performed by the intraflagellar transport (IFT) machinery. 12, 13 IFT is essential for ciliary functionality as protein synthesis does not occur within the cilium.
14

Function and Occurrence of Motile and Immotile Cilia
Motile cilia are found in only a few tissues where they transport extracellular fluid over the epithelial surface. For example, they occur on respiratory epithelial cells in the trachea where they are essential for mucus clearance, and on the apical surface of epithelial cells that line the fallopian tubes where they facilitate transportation of the (fertilized) ovum. 1 Cells with a single motile cilium also exist; sperm cells have a specialized motile cilium (flagellum) that provides their motility, and single motile cilia are also found on the apical surface of nodal cells that regulate left-right asymmetry during embryogenesis. 15 Nonmotile cilia are found on Cilia are composed of a basal body and a ciliary axoneme that protrudes from the apical plasma membrane. These two structures are linked via the transition zone (TZ) that consists of three compartments, that is, a base and two compartments filling the space between the microtubules and the axonemal membrane, which are thought to act as a diffusion barrier for regulation of ciliogenesis and signaling. Cilia contain microtubule skeletons that are composed of nine microtubule doublets that organize in a ring. A central microtubule pair is usually also present in motile cilia but not in immotile cilia. Inner and outer dynein arms, radial spokes, and nexin links are also solely present in motile cilia and actively regulate ciliary movement. During this process, dynein heavy chains of one doublet slide against microtubules of a neighboring doublet, thereby orchestrating the beating of the cilium in an ATP-dependent fashion. In both cilium types, the ciliary microtubules also function as rails for intraflagellar transport (IFT) trains that control bidirectional ciliary transport. During this process, IFT-B particles are associated with kinesin-2 motors and regulate transportation of cargo from the ciliary base to the tip, while IFT-A particles and ciliary dynein motors transport cargo in the opposite direction.
almost all quiescent cells and function differently. 16 Taken together, over the last decades, cilia demonstrated to be essential organelles that regulate a wide array of developmental, cellular, and physiologic processes wherein their motile and/or sensory capacities play a major role.
Ciliopathies
Ciliopathies are disorders that are caused by defects in motile or immotile cilia. As cilia occur on virtually all cells of the human body, their dysfunction can lead to a broad spectrum of features. 1 Common features are renal cystic disease, blindness, neural tube defects, intellectual disability, skeletal abnormalities ranging from polydactyly to abnormally short ribs and limbs, ectodermal defects, obesity, situs inversus, infertility, and respiratory anomalies. These features can occur isolated or may be part of a recognizable syndrome. Here, we describe the different types of ciliopathies, their characteristics, and to what extent they genetically and phenotypically overlap.
Neurodevelopmental Ciliopathies
Joubert syndrome (JBTS) and Meckel-Gruber syndrome (MKS) are rare neurodevelopmental disorders that genetically and phenotypically overlap. JBTS was first described by Marie Joubert in 1969 and is diagnosed when patients have hypotonia, ataxia, developmental delay, and distinctive cerebellar and brain stem malformations that can be recognized as a "molar tooth sign" (MTS; ►Fig. 2A) on magnetic resonance imaging (MRI). [18] [19] [20] JBTS patients also often present with kidney cysts, polydactyly, coloboma, retinal dystrophy, respiratory abnormalities (episodic tachypnea or apnea), oral frenula, and hepatic fibrosis. 21 The health of JBTS patients largely depends on the occurrence and severity of liver and kidney disease that require appropriate management and treatment. 19, 22 MKS shows marked clinical overlap with JBTS but is more severe and perinatal lethal. This disorder is characterized by occipital encephalocele, polycystic kidneys, polydactyly, and hepatic fibrosis (►Fig. 2B-D). 23 MKS is diagnosed when two of these four features are present or when one is present in combination with two other anomalies, including cleft lip/palate, cardiac septal defects, holoprosencephaly, agenesis of corpus callosum, Dandy-Walker malformation, microphthalmia, situs inversus, ambiguous genitalia, and shortening and bowing of long bones.
24,25
The incidence of JBTS ranges from 1:80,000 to 1:100,000 live births, 22 whereas the prevalence of MKS is less frequent at 1:140,000. 26 Exceptions exist as the occurrence of MKS in the Finnish population is as high as 1:9,000 births.
27,28
Both JBTS and MKS are usually autosomal recessive, but a few JBTS cases with X-linked inheritance have been reported. 29 by major skeletal anomalies. Besides dwarfism, polydactyly, and ectodermal dysplasia, congenital heart malformations are commonly seen in EVC patients (►Fig. 2H, L). The latter have a major influence on the prognosis for individual patients. 35 Finally, a variety of OFDSs have been reported; however, many are based on single or few cases that are not molecularly tested. 36 The best known OFD type is OFD1, 
Isolated and Syndromic Obesity
Nonsyndromic obesity is a growing problem in the general population and mainly caused by multifactorial factors. Yet in some cases isolated obesity is a mendelian disorder that results from ciliary anomalies. 41 Previously, ciliary defects had already been described in obesity syndromes such as in BBS and Alström syndrome (ALMS). Both syndromes display an autosomal recessive inheritance; however, oligogenic inheritance has also been described in BBS. 42, 43 The prevalence of BBS varies markedly between populations-from 1:160,000 in northern Europe to 1:13,500 births in isolated communities in Kuwait. 44 Cardinal BBS features are rod-cone dystrophy, obesity, polydactyly, intellectual disability, hypogonadism, and renal dysfunction (►Fig. 2I). Secondary features include cardiovascular abnormalities, craniofacial anomalies, psychomotor delay, type 2 diabetes mellitus (T2DM), and hearing loss. The clinical diagnosis of BBS is based on the presence of at least four primary features or a combination of three primary plus two secondary features. In general, the BBS phenotype evolves during the first decade of life, except for polydactyly that is present at birth; generating an accurate clinical diagnosis may therefore be challenging in infancy and early childhood. 45 BBS has an adverse prognosis, with renal impairment being a frequent and important cause of death. 46 The phenotypically related ALMS is characterized by cone-rod dystrophy, obesity, hearing impairment, cardiomyopathy, T2DM diabetes, and hepatic and renal disease. 47 A clinical diagnosis is based on the aforementioned cardinal features and differs from BBS by the presence of hearing impairment and absence of polydactyly and learning difficulties. 44 While it may be difficult to make a clinical diagnosis of BBS and ALMS in early childhood, molecular testing clearly distinguishes both disorders. To date, only one gene, ALMS1, is known to be mutated in ALMS (►Table 1). 48 In BBS mutations in 19 genes are reported to be causative (►Table 1), explaining more than 80% of the patients. 44 The protein encoded by ALMS1 and most of the proteins encoded by BBS-associated genes localize to the base of the primary cilium. ALMS1 is also found in endosomal structures and is suggested to play a role in the recycling endosome pathway. 49 The BBSome, composed of BBS1-2, 4-5, 7-9, and BBIP10, plays an important role in trafficking proteins into and out of the cilium, whereas the chaperonin complex that consists of BBS6 and BBS10-12 is required for assembly of the BBSome. 
Renal Ciliopathies
Polycystic kidneys are commonly seen in ciliopathies. The best-known renal ciliopathies are NPHP, and autosomal dominant and autosomal recessive polycystic kidney disease (ADPKD and ARPKD, respectively). ADPKD is most common with an incidence of approximately 1:1,000 and is characterized by enlarged polycystic kidneys. 52 Liver cysts and abnormalities of the vasculature and heart may also be present. Twenty NPHP genes are known so far and explain roughly one-third of the patients. All NPHP proteins reside in the basal body, transition zone, or axonemal base of primary cilia; however, they have also been found in other cellular sites such as cell junctions and nuclei. 58, 59 Mutations in NPHP genes perturb a variety of signaling cascades including Wnt, Hedgehog, Hippo, and DNA damage response signaling, which in turn disrupt renal development and tissue homeostasis.
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Primary Ciliary Dyskinesia
Most phenotypes associated by dysfunction of motile cilia result in primary ciliary dyskinesia (PCD). Cardinal symptoms are neonatal respiratory abnormalities and airway infections during childhood, which eventually develop into bronchiectasis. Patients also often present with situs inversus, dextrocardia, and infertility. 60, 61 Diagnosis of PCD is challenging due to the phenotypic overlap with other respiratory diseases such as asthma, immune deficiencies, and bronchomalacia, and the absence of clear diagnostic criteria further complicates making an accurate diagnosis. 61 The prevalence of PCD, being 1:10,000 to 1:20,000, may therefore be and underestimate. 61 Mutations in 30 genes have been associated with PCD and explain 60 to 70% of the cases.
3,61
The inheritance pattern associated with PCD is usually autosomal recessive; however, X-linked or autosomal dominant inheritance have also been reported in a few cases.
61
Roughly 60% of proteins that are encoded by PCD genes are found in protein complexes and axonemal structures that are typically found in motile cilia such as inner and outer dynein arms, radial spokes, the central microtubule pair, and nexin links (►Fig. 1), whereas the remaining proteins are cytoplasmic with a role in (pre)assembly and transportation of dynein components.
3
Why Is Genetic Screening Important?
The phenotypic spectrum of ciliopathies as a whole is very broad, but phenotypic overlap between certain ciliopathies can be marked, such as in JBTS and MKS or BBS and ALMS. 20 A correct diagnosis can thus not always be made solely based on the clinical phenotype but requires molecular testing. Molecular information facilitates making an accurate diagnosis and is therefore essential for proper genetic counseling, prognosis, recurrence risk estimation, and clinical management in the clinic. In the past years, gene panels and exomes have been analyzed by next-generation sequencing (NGS) technologies. This resulted in the detection of numerous pathogenic mutations and dozens of novel disease genes in a nick of time. NGS thus enormously facilitated our ability to make an early diagnosis and to recognize important genotype-phenotype correlations. 62, 63 This knowledge contributes to the clinician's ability to correctly inform patients about expected disease progression and allows clinicians to form appropriate interdisciplinary teams leading to optimal clinical care and disease management. For example, early diagnosis is highly beneficial to PCD patients in whom progression to irreversible lung disease continues unless treated early on. 64 Gene and mutation identification also allows for development of personalized therapies such as targeted gene therapy. This is important as no cures are available for ciliopathies to date. Gene therapy successes have been booked in patients with a variety of hereditary disorders, 65-68 including retinal degeneration. The latter is a common feature in many ciliopathies and is probably treatable in the future. 69 In addition to the retina, researchers also started to investigate possibilities for gene therapy in ciliopathies affecting the respiratory system. [70] [71] [72] For example, ciliary beating was restored in ex vivo cell cultures from PCD patients harboring mutations in DNAI1 by introducing a healthy copy of this gene via lentiviral transduction. 90 and 65% of PCD patients with panels. 91 The advantage of gene panel testing versus genomic methods such as whole-exome sequencing (WES), whereby all exons of the genome are sequenced, is that panels usually result in higher coverage data at a relatively low cost and with high-throughput. 92, 93 In addition, the chance of identification of incidental findings, which are clinically relevant findings that are unrelated to the clinical problem for which screening was initially intended, is extremely low when only known ciliopathy-specific genes are being sequenced 94 ; however, it is difficult to add new genes to existing gene panels. 94 The possibility of detection of incidental findings is an important concern when analyzing WES data, however, WES has proven to be highly successful for the identification of a mutation in a gene that has not previously been implicated in ciliary disease. Furthermore, retrospective analysis of the data is possible. 94 A recent research study
reported that WES provides a molecular diagnosis in 44% of ciliopathy patients.
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Diagnostics
In past and current genome diagnostics for ciliopathies, prescreening methods such as (SNP) microarrays for homozygosity mapping (and copy number detection, CNV) or targeted panels with only known mutations in ciliary disease genes have been used to reduce costs by limiting the list of genes to be tested by gene-specific methods such as Sanger sequencing. More recently, WES started to be implemented as a diagnostic test for ciliopathies and is considered to be cost-effective when a clinician needs to investigate more than two genes to identify the genetic cause of disease, a scenario that often applies when a ciliopathy patient presents in the clinic considering the enormous genetic heterogeneity in these disorders. 95, 96 While incidental findings are a concern in WES, these can be easily circumvented in diagnostics by first (or only) analyzing known ciliopathy genes and leaving the remainder of WES data concealed. This approach has proven to be an effective tool for gene and mutation identification with reasonable throughput and acceptable costs. 96, 97 Diagnostic WES has an estimated success rate of approximately 30% for ciliopathies in our institute (personal communication, D. Lugtenberg and www.genomediagnosticsnijmegen.nl). Other groups reported general success rates for rare diseases that vary between 20 and 45% based on various studies that include thousands of patients.
98-101
Current Next-Generation Sequencing Obstacles
Although NGS sequencing has tremendously improved mutation detection for numerous disorders, ciliopathies included, there are still several hurdles to take with respect to accurate variant detection and prioritization.
Technical Challenges
In WES the coverage, referring to the number of times that a genomic region is read, is not always complete for each ciliopathy gene, which prevents detection of causative variants. One gene that is not sufficiently covered in any standard WES procedure is PKD1. This is explained by the existence of six PKD1 pseudogenes that share greater than 97% sequence identity with the first 33 exons of PKD1, which complicates standard alignment algorithms. 
Future Perspectives
This review discussed mutation detection for ciliary disorders through gene panels and WES in both research and diagnostics. We did not highlight the power of whole-genome sequencing yet, while this is the technology of the future. The general advantage of WGS compared with WES is that it leads to improved mutation detection in protein-coding DNA. 116 In addition, WGS allows detection of variation in noncoding genomic regions. Although our understanding of variation in noncoding DNA is still poor, future research will allow for improved interpretation of variants in these regions, probably in particular in conserved regulatory elements such as promoters, enhancers, insulators, and other regulators. 117 Other WGS challenges concern data storage and throughput, which rely on the availability of excellent bioinformatic platforms; however, WGS platforms and procedures are improving and fastening as we speak. For example, it was recently shown that it is possible to effectively conduct WGS and data analysis within 26 to 50 hours periods in ill neonates. 118, 119 This strategy is also of interest for newborns with a suspected ciliary disorder as clinical features of classic syndromes may be incomplete and difficult to recognize in infancy, while molecular knowledge allows accurate and early diagnosis and prognosis and directs decisions for optimal disease management in these children. Besides implementing NGS for ciliopathies in postnatal diagnostics, there also is a need to conduct such testing prenatally as clinical features of ciliopathies may present as early as the first trimester of pregnancy. 120 In addition, improved prenatal testing also allows for optimal management and counseling for parents who have a risk of giving birth to a child with a ciliopathy. The future implementation of NGS-based methods in prenatal diagnostics will rely on short turnaround times of clinical reports as limited time is available for counseling and decision making. Prenatal diagnostics will further benefit from the possibility to conduct genetic screening on fetal DNA derived from maternal blood as that avoids the need for invasive amniocentesis and chorionic villus sampling. Notably, NGS is already successfully being used for detection of aneuploidies and CNVs in fetal DNA extracts from maternal blood, whereas technological advances may allow for genome-wide single nucleotide variation (SNV) detection in fetal-maternal DNA in the future.
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In conclusion, NGS-based screening revolutionized the ciliopathy research and diagnostics in recent years, and this process is still ongoing. While technical and bioinformatic challenges remain, NGS methods are gradually being implemented in clinical laboratories with reasonable throughput, for acceptable costs, and with significant mutation identification success for ciliopathies. In the future, return of molecular reports will accelerate with turnaround times of only one or a few days, and screening of ciliopathy panels, WES, and WGS will probably evolve as part of noninvasive procedures in prenatal genome diagnostics. These developments will further contribute to improved health care for families affected by ciliary disorders.
